ID   HTRA3_RAT               Reviewed;         459 AA.
AC   D3ZA76; D3ZLW3;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   02-OCT-2024, entry version 86.
DE   RecName: Full=Serine protease HTRA3;
DE            EC=3.4.21.-;
DE   AltName: Full=High-temperature requirement factor A3;
DE   AltName: Full=Pregnancy-related serine protease;
DE   Flags: Precursor;
GN   Name=Htra3; Synonyms=Prsp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=19415717; DOI=10.1002/jez.b.21288;
RA   Bowden M., Drummond A.E., Salamonsen L.A., Findlay J.K., Nie G.;
RT   "Evolutionary conservation of mammalian HTRA3 and its developmental
RT   regulation in the rat ovary.";
RL   J. Exp. Zool. B Mol. Dev. Evol. 312:701-713(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS 1 AND 2).
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
CC   -!- FUNCTION: Serine protease that cleaves beta-casein/CSN2 as well as
CC       several extracellular matrix (ECM) proteoglycans such as decorin/DCN,
CC       biglycan/BGN and fibronectin/FN1. Inhibits signaling mediated by TGF-
CC       beta family proteins possibly indirectly by degradation of these ECM
CC       proteoglycans (By similarity). May act as a tumor suppressor.
CC       Negatively regulates, in vitro, trophoblast invasion during placental
CC       development and may be involved in the development of the placenta in
CC       vivo. May also have a role in ovarian development, granulosa cell
CC       differentiation and luteinization (By similarity).
CC       {ECO:0000250|UniProtKB:P83110, ECO:0000250|UniProtKB:Q9D236}.
CC   -!- SUBUNIT: Homotrimer (By similarity). Interacts with TGFB1; the
CC       interaction inhibits TGFB-mediated signaling. Interacts with BMP4; the
CC       interaction inhibits BMP4-mediated signaling. Interacts with TGFB2,
CC       GDF5 and MYH9 (By similarity). {ECO:0000250|UniProtKB:P83110,
CC       ECO:0000250|UniProtKB:Q9D236}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P83110}.
CC       Note=Secretion increased during decidualization of endometrial stromal
CC       cells. {ECO:0000250|UniProtKB:P83110}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=D3ZA76-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=D3ZA76-2; Sequence=VSP_043827, VSP_043828;
CC   -!- TISSUE SPECIFICITY: Expressed in the ovary, essentially in granulosa
CC       cells in a follicle-stage specific manner. Highest levels found in
CC       large luteinizing granulosa cells. {ECO:0000269|PubMed:19415717}.
CC   -!- DEVELOPMENTAL STAGE: In the developing ovary, high expression,
CC       especially of the longer isoform, at 12 days of age after birth.
CC       Expression restricted to the interstitial cells surrounding the
CC       follicles. Levels are further increased during ovarian maturation.
CC       {ECO:0000269|PubMed:19415717}.
CC   -!- SIMILARITY: Belongs to the peptidase S1C family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; NP_001257956.1; NM_001271027.1. [D3ZA76-1]
DR   RefSeq; XP_017454804.1; XM_017599315.1. [D3ZA76-2]
DR   AlphaFoldDB; D3ZA76; -.
DR   SMR; D3ZA76; -.
DR   STRING; 10116.ENSRNOP00000010852; -.
DR   PhosphoSitePlus; D3ZA76; -.
DR   PaxDb; 10116-ENSRNOP00000010852; -.
DR   Ensembl; ENSRNOT00000010852.9; ENSRNOP00000010852.5; ENSRNOG00000008182.9. [D3ZA76-1]
DR   Ensembl; ENSRNOT00000103981.1; ENSRNOP00000093047.1; ENSRNOG00000008182.9. [D3ZA76-2]
DR   Ensembl; ENSRNOT00055028075; ENSRNOP00055022591; ENSRNOG00055016546. [D3ZA76-1]
DR   Ensembl; ENSRNOT00060036816; ENSRNOP00060030327; ENSRNOG00060021239. [D3ZA76-1]
DR   Ensembl; ENSRNOT00065053751; ENSRNOP00065044193; ENSRNOG00065031168. [D3ZA76-1]
DR   GeneID; 360959; -.
DR   KEGG; rno:360959; -.
DR   AGR; RGD:1308120; -.
DR   CTD; 94031; -.
DR   RGD; 1308120; Htra3.
DR   eggNOG; ENOG502QT3F; Eukaryota.
DR   GeneTree; ENSGT00940000159570; -.
DR   HOGENOM; CLU_020120_6_2_1; -.
DR   InParanoid; D3ZA76; -.
DR   OMA; AYVVTNH; -.
DR   OrthoDB; 2159919at2759; -.
DR   TreeFam; TF323480; -.
DR   PRO; PR:D3ZA76; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000008182; Expressed in heart and 19 other cell types or tissues.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008236; F:serine-type peptidase activity; ISS:UniProtKB.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; ISS:UniProtKB.
DR   CDD; cd00104; KAZAL_FS; 1.
DR   CDD; cd00987; PDZ_serine_protease; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 2.40.10.120; -; 1.
DR   Gene3D; 3.30.60.30; -; 1.
DR   Gene3D; 4.10.40.20; -; 1.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR000867; IGFBP-like.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001940; Peptidase_S1C.
DR   PANTHER; PTHR22939; SERINE PROTEASE FAMILY S1C HTRA-RELATED; 1.
DR   PANTHER; PTHR22939:SF14; SERINE PROTEASE HTRA3; 1.
DR   Pfam; PF00219; IGFBP; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF13180; PDZ_2; 1.
DR   Pfam; PF13365; Trypsin_2; 1.
DR   PRINTS; PR00834; PROTEASES2C.
DR   SMART; SM00121; IB; 1.
DR   SMART; SM00280; KAZAL; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS51323; IGFBP_N_2; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Disulfide bond; Hydrolase; Protease;
KW   Reference proteome; Secreted; Serine protease; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..459
FT                   /note="Serine protease HTRA3"
FT                   /id="PRO_0000417598"
FT   DOMAIN          27..90
FT                   /note="IGFBP N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DOMAIN          76..134
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DOMAIN          365..450
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          181..346
FT                   /note="Serine protease"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        197
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P83110"
FT   ACT_SITE        233
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P83110"
FT   ACT_SITE        311
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P83110"
FT   DISULFID        31..54
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        35..56
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        40..57
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        45..60
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        68..82
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        76..87
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        89..107
FT                   /evidence="ECO:0000305"
FT   DISULFID        96..132
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   VAR_SEQ         357..363
FT                   /note="DWKKRFI -> ALSRALH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:19415717"
FT                   /id="VSP_043827"
FT   VAR_SEQ         364..459
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:19415717"
FT                   /id="VSP_043828"
SQ   SEQUENCE   459 AA;  49257 MW;  BFD7DDD34305C818 CRC64;
     MQARALLPAT LATLATLAVS VLAREPPAAP CPARCDVSRC PSPRCPGGYV PDLCNCCLVC
     AASEGEPCGR PLDSPCGDSL ECVRGVCRCR WTHTVCGTDG HTYADVCALQ AASRRALQIS
     GTPVRQLQKG ACPSGLHQLT SPRYKFNFIA DVVEKIAPAV VHIELFLRHP LFGRNVPLSS
     GSGFIMSEAG LIVTNAHVVS SSNTASGRQQ LKVQLQNGDA YEATIQDIDK KSDIATILIH
     PNKKLPVLLL GHSADLRPGE FVVAIGSPFA LQNTVTTGIV STAQRDGKEL GLRDSDMDYI
     QTDAIINYGN SGGPLVNLDG EVIGINTLKV AAGISFAIPS DRITRFLSEF QDKHVKDWKK
     RFIGIRMRTI TPSLVEELKT ANPDFPAVSS GIYVQEVVPN SPSQRGGIQD GDIIVKVNGR
     PLVDSSELQE AVLNESSLLL EVRRGNDDLL FSIMPEVVM
//
